zonisamide has been researched along with Kahler Disease in 1 studies
Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Zonisamide was changed to sodium valproate." | 1.31 | Smoldering myeloma associated with zonisamide treatment. ( Ando, Y; Asai, S; Hotta, T; Kobayashi, H; Miyachi, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asai, S | 1 |
| Miyachi, H | 1 |
| Kobayashi, H | 1 |
| Hotta, T | 1 |
| Ando, Y | 1 |
1 other study available for zonisamide and Kahler Disease
| Article | Year |
|---|---|
Smoldering myeloma associated with zonisamide treatment.
Topics: Adult; Agammaglobulinemia; Anticonvulsants; Epilepsy, Generalized; Humans; Immunoglobulin lambda-Cha | 2002 |